Our results showed that daphnetin mainly reduced the phosphorylation of AKT, which could affect the TGF-β-dependent activation of inflammatory cells as well as the epithelial cells in BLM-treated mice. The gene discussed is TGFB1; the disease is Bloom syndrome.